Global Pharma-Bio Industry Boasts More Than $87 Billion in Projects with Future Kickoffs, an Industrial Info Market Brief

---

The Pharmaceutical & Biotech Industry has well over 4,400 reported capital and maintenance projects on the books globally, with a healthy potential investment value of more than $87 billion.

Reported activity spans the entire spectrum of industry sectors, including projects like Pfizer's $450 million plan to add a modular aseptic processing (MAP) facility at its global manufacturing site in Kalamazoo, Michigan, and contract manufacturer Hovione's $232 million grassroot plant that would produce active pharmaceuticals ingredients (APIs) and other products for the European, Japanese and North American markets.

See project map below.